Sign up to save your podcasts
Or
Share Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial
Ozempic, Wegovy, Semaglutide are reducing heart disease in non diabetics! The SELECT outcomes trial has demonstrated a 20% reduction in cardiovascular outcomes in non diabetics.
https://dralo.net/links
View all episodes
By Cardiologist & Personal Trainer Dr. Alo
4.9
141141 ratings
Ozempic, Wegovy, Semaglutide are reducing heart disease in non diabetics! The SELECT outcomes trial has demonstrated a 20% reduction in cardiovascular outcomes in non diabetics.
https://dralo.net/links
More shows like Dr Alo Show
View all
The Model Health Show
7,365 Listeners
The Jesse Chappus Show
1,548 Listeners
Heart Doc VIP with Dr. Joel Kahn
490 Listeners
The Proof with Simon Hill
2,627 Listeners
The Genius Life
4,914 Listeners
Dhru Purohit Show
3,527 Listeners
The Dr. Hyman Show
9,264 Listeners
The Peter Attia Drive
9,083 Listeners
The Hormone Solution with Karen Martel
330 Listeners
Metabolic Freedom With Ben Azadi
1,110 Listeners
The Holistic GLP-1 Podcast with Elizabeth McGann
50 Listeners
Huberman Lab
29,196 Listeners
The Metabolic Classroom with Dr. Ben Bikman
231 Listeners
Docs Who Lift
394 Listeners
The Dr. Gabrielle Lyon Show
1,185 Listeners